Wall Street hit by healthcare slump; U.S. yields rise

Go back to Wall Street hit by healthcare slump; U.S. yields rise

Jefferies Reiterates Buy Following Verizon Communications (VZ) 3Q Results

October 21, 2015 9:04 AM EDT

Jefferies reiterated a Buy rating and $53.00 price target on Verizon Communications (NYSE: VZ) following the company's 3Q15 earnings results.

Analyst Mike McCormack commented, "Results reflected better profitability in both Wireless and Wireline. Wireless continues to perform well in a challenging environment, evident in... More

Allergan (AGN) Announces Launch of Refresh Optive Gel Drops

October 21, 2015 8:03 AM EDT

Allergan (NYSE: AGN) announced the launch of the over-the-counter artificial tear REFRESH OPTIVE® Gel Drops, a new aqueous gel expertly designed for patients who need or desire a more viscous artificial tear option to relieve their Dry Eye symptoms. From REFRESH®, the creators of the number one doctor recommended brand of artificial tears1, new REFRESH OPTIVE® Gel Drops are formulated with Glycerin and a unique blend of the active ingredient CMC which binds to the eye surface to provide long-lasting relief from Dry Eye discomfort.

"With REFRESH OPTIVE® Gel Drops, eye care... More

Cowen Reiterates Market Perform as Verizon Communications (VZ) Reports In-Line Results

October 21, 2015 6:55 AM EDT

Cowen reiterated a Market Perform rating and $48.00 price target on Verizon Communications (NYSE: VZ) following the company's 3Q15 earnings results. VZ reported mostly in line 3Q15 results including rev/EPS of $33.16B/$1.04 vs. the Streets $32.97B/$1.02E.

Analyst Colby Synesael commented, "VZ... More